Search your stocks

Share

Profile

VALIANTLABValiant Laboratories Ltd.

87.44(+0.51%)

1W: +3.18%

1M: -2.65%

1Y: -42.97%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Consistent revenue growth over the last four quarters indicates strong demand for products.
Improved operating margins suggest better cost management and operational efficiency.
Increased R&D investment shows commitment to innovation and long-term growth.

NEGATIVES

Declining net profit margin raises concerns about profitability sustainability.
High debt levels could pose risks, particularly in a rising interest rate environment.
Fluctuating raw material costs might impact future profitability and pricing strategies.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		59.55	40.52	30.59	18.88	21.48	35.23	57.79	46.82
Expenses		61.44	47.34	35.66	21.86	28.74	35.19	54.53	45.03
Operating Profit		-1.89	-6.82	-5.07	-2.98	-7.27	0.04	3.25	1.79
Other Income		2.96	1.77	2.50	2.81	3.36	1.58	-2.31	0.66
Interest		0.02	0.02	0.02	0.05	0.01	0.06	0.06	0.07
Depreciation		0.49	0.49	0.52	0.53	0.52	0.52	0.52	0.53
Profit Before Tax		1.06	-5.04	-2.57	-0.16	-3.91	1.62	0.94	2.45
Tax		0.27	-1.54	-1.33	0.35	0.83	-0.73	0.24	0.63
Net Profit		0.79	-3.50	-1.24	-0.51	-4.74	2.34	0.70	1.82
Eps in Rs		0.24	-0.81	-0.33	-0.12	-1.09	0.54	0.16	0.42